fluorodeoxyglucose f18 has been researched along with Angiogenesis, Pathologic in 90 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (1.11) | 18.2507 |
2000's | 30 (33.33) | 29.6817 |
2010's | 53 (58.89) | 24.3611 |
2020's | 6 (6.67) | 2.80 |
Authors | Studies |
---|---|
Balasse, L; Blot-Chabaud, M; Brige, P; Dignat-George, F; Fernandez, S; Garrigue, P; Guillet, B; Hache, G; Hubert, F; Moyon, A; Nail, V; Rochais, F | 1 |
Abazari, MA; Ghazani, MA; Kashkooli, FM; Rahmim, A; Soltani, M | 1 |
Russell, D; Scott, H; Skagen, K; Skjelland, M; Zamani, M | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Jiang, H; Jiang, HJ; Wang, ZC; Zhang, MY; Zhang, RJ | 1 |
Bonomo, L; Calandriello, L; Congedo, MT; Del Ciello, A; Giordano, A; Infante, A; Larici, AR; Leccisotti, L; Poscia, A; Sica, G | 1 |
Banks, TI; Hristov, D; Kidd, EA; von Eyben, R | 1 |
Adler, SS; Basuli, F; Choyke, PL; Green, MV; Jagoda, EM; Kuo, F; Roy, J; Seidel, J; Williams, MR; Wong, K; Xu, B | 1 |
Ashwathanarayana, AG; Kavanal, AJ; Kumar, S; Mittal, BR; Rana, N; Shukla, J; Singh, G; Vatsa, R | 1 |
Höhn, AK; Meyer, HJ; Purz, S; Sabri, O; Surov, A; Wienke, A | 1 |
Asosingh, K; Comhair, SA; Davis, L; DiFilippo, FP; Dostanic, I; Erzurum, SC; Graham, BB; Lundgrin, EL; Neumann, DR; Park, MM; Sharp, J; Tang, WH; Thomas, JD; Tuder, RM | 1 |
Freesmeyer, M; Lopatta, E; Marlowe, RJ; Opfermann, T; Schierz, JH; Settmacher, U; Stallmach, A; Steenbeck, J | 1 |
El-Chemaly, S; Gahl, WA; Gochuico, BR; Malide, D; Moss, J; Nathan, SD; Rosas, IO; Yao, J | 1 |
Chen, HJ; Cheng, LQ; Gai, JJ; Li, J; Liu, HB; Liu, JJ; Wang, Y; Xie, LX; Yin, DY; Zhang, XW; Zhao, XH | 1 |
Backes, WH; Bucerius, J; Daemen, MJ; Hermeling, E; Kooi, ME; Kwee, RM; Mess, WH; Truijman, MT; van Hoof, RH; van Oostenbrugge, RJ; Wildberger, JE | 1 |
Endo, M; Kaira, K; Kenmotsu, H; Murakami, H; Naito, T; Nakajima, T; Ohde, Y; Ono, A; Takahashi, T; Yamamoto, N | 1 |
Hirokawa, E; Kishino, O; Kuji, I; Matsuura, K; Nakamiya, N; Oda, M; Osaki, A; Saeki, T; Sano, H; Shigekawa, T; Shimada, H; Suzuki, H; Ueda, S; Yamashita, Y | 1 |
Endo, M; Hanaoka, H; Kaira, K; Koh, Y; Nakajima, T; Ohde, Y; Oriuchi, N; Serizawa, M; Takahashi, T; Yamaguchi, A; Yamamoto, N | 1 |
Chen, X; Li, F; Yin, Y; Zhang, F; Zhang, X; Zheng, K; Zhu, Z | 1 |
Beer, AJ; Braren, R; Bussemer, J; Frank, A; Gille, H; Haller, B; Hohlbaum, AM; Kosanke, Y; Meier, R; Neff, F; Rummeny, EJ; Schwaiger, M; Schwarzenböck, S; Wildgruber, M | 1 |
Belkin, M; Di Carli, MF; Folco, EJ; Jerosch-Herold, M; Kwong, RY; Libby, P; Murthy, VL; Nahrendorf, M; Ozaki, CK; Sukhova, GK; Taqueti, VR; Weissleder, R | 1 |
Ahn, SY; Cheon, GJ; Choi, BI; Han, JK; Joo, I; Lee, ES; Lee, JM; Lee, SJ | 1 |
Eskola, O; Grénman, R; Grönroos, TJ; Kronqvist, P; Laine, J; Lehtiö, K; Minn, H; Söderström, KO; Solin, O; Viljanen, T | 1 |
Joshi, FR; Rajani, NK; Rudd, JH; Tarkin, JM | 1 |
Chikamatsu, K; Kaira, K; Sakakura, K; Toyoda, M; Tsushima, Y; Yokobori, Y | 1 |
Bezak, E; Jennings, M; Marcu, LG | 1 |
Hwang, H; Jeong, HJ; Jeong, HS; Kim, J; Kwon, J; Lim, S; Na, KS; Oh, PS; Sohn, MH | 1 |
Alessio, AM; Caldwell, JH; Ferguson, MS; Hatsukami, TS; Hippe, DS; Kerwin, WS; Kohler, TR; Liu, J; Martinez-Malo, V; Miyaoka, RS; Pimentel, K; Yuan, C | 1 |
Abraham, MR; Afzal, J; Chan, AT; Elisseeff, JH; Karakas, MF; Lin, X; Pomper, MG; Rittenbach, A; Steenbergen, CJ; Tsui, BM; Vakrou, S; Wahl, RL | 1 |
Alavi, A; Gholami, S; Høilund-Carlsen, PF; Kwee, TC; Rubello, D; Werner, TJ | 1 |
Cook, GJ; Goh, V; Szlosarek, P; Szyszko, TA; Yip, C | 1 |
Cheng, W; Cui, Y; Hai, W; Liang, S; Liu, H; Wang, D; Yin, B; Zhang, C | 1 |
Berriolo-Riedinger, A; Brunotte, F; Cochet, A; Depardon, E; Dygai-Cochet, I; Fumoleau, P; Humbert, O; Kanoun, S; Lassere, M; Riedinger, JM; Tisserand, S; Toubeau, M; Vrigneaud, JM | 1 |
Chowdhury, MM; Evans, NR; Rudd, JH; Sriranjan, RS; Tarkin, JM | 1 |
Cheon, GJ; Chung, JK; Kang, KW; Kim, EE; Kim, YI; Lee, DS; Moon, WK; Paeng, JC; Yoon, HJ | 1 |
Faust, A; Hermann, S; Honold, L; Schäfers, M; Vrachimis, A | 1 |
Jung, JH; Kim, SE; Lee, BC; Lee, MS; Park, HS; Yoo, JS | 1 |
Allemann, P; Jreige, M; Pomoni, A; Prior, JO; Van Der Gucht, A | 1 |
Bazmara, H; Casey, ME; Rahmim, A; Sefidgar, M; Soltani, M; Subramaniam, RM; Wahl, RL | 1 |
Ding, B; Lin, H; Qu, Y; Yan, F; Yang, G; Zhang, H; Zhang, M | 1 |
Crukley, C; Desjardins, L; Hadway, J; Lee, TY; Morrison, L; Stewart, E; Wang, Y | 1 |
Gatenby, RA; Gillies, RJ; Robey, I | 1 |
Cheng, C; Dimitrakopoulou-Strauss, A; Haberkorn, U; Klippel, S; Koczan, D; Pan, L; Strauss, LG; Willis, S | 1 |
Endo, K; Endou, H; Higuchi, T; Hisada, T; Imai, H; Ishikita, T; Ishizuka, T; Kaira, K; Kanai, Y; Mori, M; Nakajima, T; Oriuchi, N; Shimizu, K; Sunaga, N; Yanagitani, N | 1 |
Ceelen, W; Smeets, P | 1 |
Gauthier, H | 1 |
Boerman, OC; Dijkgraaf, I | 1 |
Aquaro, GD; Bartoli, A; Bianchi, F; Bonavita, F; Cantoni, S; Cavallini, C; Frascari, I; Lionetti, V; Maioli, M; Olivi, E; Pasquinelli, G; Recchia, FA; Scarlata, I; Tassinari, R; Vaccari, V; Valente, S; Ventura, C | 1 |
Fayad, ZA; Glover, DK; Johnson, LL; Lanza, GM; Sadeghi, MM | 1 |
Caamaño, AG; Figueiras, RG; Goh, V; Martin, CV; Naveira, AB; Padhani, AR | 1 |
Davidson, T; Ell, PJ; Endozo, R; Groves, AM; Kelleher, T; Keshtgar, MR; Malhotra, A; Miles, KA; Rodriguez-Justo, M; Shastry, M | 1 |
Burkholder, I; Combs, SE; Essig, M; Giesel, FL; Haberkorn, U; Henze, M; Kauczor, HU; Kroll, A; Meissner, M; Stieltjes, B; Tüttenberg, J; Vogt-Schaden, M; Weber, MA; Zimmer, F; Zoubaa, S | 1 |
Antinolfi, F; Antinolfi, G; Barra, E; Brunese, L; Cappabianca, S; Caputi, M; Catalano, M; De Rimini, ML; De Rosa, I; De Rosa, N; Di Matteo, A; Grassi, R; Greco, B; Muto, P; Muto, R; Petrillo, M; Piccolo, S; Porto, A; Reginelli, A; Ronza, F; Rossi, G; Rotondo, A; Setola, F | 1 |
Guleryuz, S; Manning, HC; Smith, RA | 1 |
Chen, X; Gao, H; Mohamedali, KA; Niu, G; Quan, Q; Rosenblum, MG; Sun, X; Yan, Y; Yang, M; Zhang, W | 1 |
Bernstine, H; Braun, M; Carmi, R; Groshar, D; Lamash, Y; Sosna, J; Steinmetz, A; Stern, D; Yefremov, N | 1 |
Fujibayashi, Y; Hata, H; Kitagawa, Y; Kotsuji, M; Nakamura, M; Okazawa, H; Sano, K; Yamazaki, Y; Yonekura, Y | 1 |
Graebe, M; Hag, AM; Hoejgaard, L; Kjaer, A; Pedersen, SF; Sillesen, H | 1 |
Calcagno, C; Dickson, SD; Fayad, ZA; Fisher, EA; Fuster, V; Hayashi, K; Lin, J; Moon, MJ; Moshier, E; Mounessa, JS; Nicolay, K; Roytman, M; Rudd, JH; Tsimikas, S; Vucic, E | 1 |
Hirami, Y; Maeda, A; Nakata, M; Saisho, S; Shimizu, K; Yasuda, K; Yukawa, T | 1 |
Freesmeyer, M; Lopatta, E; Opfermann, T; Schierz, JH; Settmacher, U; Steenbeck, J | 1 |
Arnould, L; Berriolo-Riedinger, A; Brunotte, F; Cochet, A; Coudert, B; Dygai-Cochet, I; Fumoleau, P; Humbert, O; Khoury, B; Pigeonnat, S; Toubeau, M; Touzery, C; Vrigneaud, JM | 1 |
Blackman, G; Ell, P; Endozo, R; Engledow, A; Goh, V; Groves, AM; Halligan, S; Peck, J; Rodriguez-Justo, M; Shastry, M; Taylor, S | 1 |
Backes, H; Bjerkvig, R; Brekka, N; Hoehn, M; Jacobs, AH; Jikeli, JF; Miletic, H; Monfared, P; Neumaier, B; Niclou, SP; Stieber, D; Talasila, KM; Tavitian, B; Thorsen, F; Viel, T; Waerzeggers, Y; Wang, J; Winkeler, A | 1 |
Bäuerle, T; Bretschi, M; Cheng, C; Dimitrakopoulou-Strauss, A; Semmler, W; Strauss, LG; Witt, H | 1 |
Hoekstra, CJ; Hoekstra, OS; Lammertsma, AA; Smit, EF; Stroobants, SG; Vansteenkiste, JF | 1 |
Abbruzzese, JL; Baker, C; Bucana, C; Charnsangavej, C; Davis, DW; Ellis, LM; Herbst, RS; Hess, KR; Kim, HW; Madden, TL; McConkey, DJ; Mullani, NA; O'Reilly, MS; Pluda, J; Rashid, A; Roach, J; Tran, HT | 1 |
Bradley, JD; Chapman, JD; Eary, JF; Haubner, R; Larson, SM; Michalski, JM; Okunieff, PG; Strauss, HW; Ung, YC; Welch, MJ | 1 |
Hattori, K; Nakajima, M; Nakashima, E; Oku, N; Tamura, M; Tsukada, H; Unno, K; Yonezawa, S | 1 |
Fukuda, K; Koh, T; Kunishima, S; Taniguchi, H; Yamagishi, H | 1 |
Canniff, KM; Donnelly, EF; Fleischer, AC; Hallahan, DE; Niermann, KJ; Rothenberg, ME; Yankeelov, TE | 1 |
Badve, S; Calley, C; Emerson, RE; Goulet, R; Hutchins, GD; Kopecky, K; Miller, KD; Sledge, GW; Soule, SE; Storniolo, A | 1 |
Bading, JR; Bart, R; Bremner, R; Chen, X; Conti, PS; Hou, Y; Park, R; Sievers, E; Tohme, M | 1 |
Helmberger, T; Jacobs, TF; Münzing, W; Pöpperl, G; Schmid, R; Tatsch, K | 1 |
Griffiths, MR; Keith, CJ; Miles, KA | 1 |
Campa, MJ; Furumai, R; Howard, BA; Patz, EF; Rabbani, ZN; Vujaskovic, Z; Wang, XF | 1 |
Belkacémi, Y; Comet, B; Kerrou, K; Lartigau, E; Tsoutsou, PG | 1 |
Berlangieri, SU; Cher, LM; Fabinyi, G; Hannah, A; Lawrentschuk, N; Murone, C; O'Keefe, GJ; Papenfuss, A; Ramdave, S; Sachinidis, JI; Scott, AM | 1 |
Guo, J; Higashi, K; Katsuda, S; Oguchi, M; Sakuma, T; Takegami, T; Toga, H; Tonami, H; Ueda, Y; Yamamoto, I; Yokota, H | 1 |
Chin, K; Finger, PT; Iacob, CE | 1 |
Cherk, MH; Foo, SS; Knight, SR; Murone, C; O'Keefe, GJ; Papenfuss, AT; Poon, AM; Sachinidis, JI; Saunder, TH; Scott, AM | 1 |
Fleischer, AC; Hallahan, DE; Huamani, J; Kim, DW; Niermann, KJ; Wilson, WD; Yankeelov, TE | 1 |
Airley, RE; Mobasheri, A | 1 |
Brink, I; Hentschel, M; Mix, M; Moser, E; Nitzsche, EU; Paulus, T | 1 |
Coleman, RL; Gershenson, DM; Han, LY; Jennings, N; Kamat, AA; Kim, TJ; Kundra, V; Landen, CN; Langley, R; Lin, YG; Lu, C; Merritt, WM; Ravoori, M; Sood, AK; Spannuth, WA | 1 |
Brindle, K | 1 |
Dunphy, MP; Strauss, HW | 1 |
Briley-Saebo, KC; Calcagno, C; Cornily, JC; Fayad, ZA; Fuster, V; Goldschlager, G; Hyafil, F; Machac, J; Mani, V; Rudd, JH | 1 |
Blasberg, RG; Claffey, KP; Finn, R; Joshi, A; Joshi, R; Miyagawa, T; Oku, T; Sasajima, T; Tjuvajev, JG | 1 |
Bellomi, M; Fazio, F; Landoni, C; Leo, F; Leon, ME; Pastorino, U; Pelosi, G; Picchio, M; Solli, PG; Sonzogni, A; Spaggiari, L; Veronesi, G | 1 |
17 review(s) available for fluorodeoxyglucose f18 and Angiogenesis, Pathologic
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
PET imaging of atherosclerosis.
Topics: Atherosclerosis; Calcinosis; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoxia; Inflammation; Neovascularization, Pathologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Risk Assessment; Stroke; Tomography, X-Ray Computed | 2015 |
PET-specific parameters and radiotracers in theoretical tumour modelling.
Topics: Cell Proliferation; Coordination Complexes; Dideoxynucleosides; Diffusion; Fluorodeoxyglucose F18; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glucose; Humans; Hydrogen-Ion Concentration; Hypoxia; Misonidazole; Models, Theoretical; Multimodal Imaging; Neoplasms; Neovascularization, Pathologic; Organometallic Compounds; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Thiosemicarbazones; Tomography, X-Ray Computed | 2015 |
The role of new PET tracers for lung cancer.
Topics: Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Neovascularization, Pathologic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Imaging unstable plaque.
Topics: Animals; Arteries; Calcinosis; Cardiovascular Diseases; Coronary Angiography; Fluorodeoxyglucose F18; Humans; Hypoxia; Inflammation; Magnetic Resonance Imaging; Mice; Molecular Probes; Neovascularization, Pathologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Risk; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2016 |
New molecular probes of vascular inflammation.
Topics: Animals; Apoptosis; Atherosclerosis; Calcinosis; Cardiology; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Hypoxia; Inflammation; Mice; Molecular Probes; Neovascularization, Pathologic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Translational Research, Biomedical | 2016 |
Causes and consequences of increased glucose metabolism of cancers.
Topics: Cell Hypoxia; Cell Transformation, Neoplastic; Evolution, Molecular; Female; Fluorodeoxyglucose F18; Game Theory; Glucose; Glycolysis; History, 19th Century; History, 20th Century; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Oncogenes; Radionuclide Imaging; Radiopharmaceuticals | 2008 |
[Positron emission tomography and evaluation of response to targeted therapies].
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cell Hypoxia; Cell Proliferation; Choline; ErbB Receptors; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Lipid Metabolism; Lung Neoplasms; Neoplasms; Neovascularization, Pathologic; Piperazines; Positron-Emission Tomography; Protein Biosynthesis; Protein Kinases; Pyrimidines; Radiopharmaceuticals; Receptors, Androgen; Receptors, Estrogen; TOR Serine-Threonine Kinases | 2009 |
Radionuclide imaging of tumor angiogenesis.
Topics: Alternative Splicing; Angiogenesis Inhibitors; Animals; Endothelium, Vascular; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Integrin alphaVbeta3; Magnetic Resonance Imaging; Matrix Metalloproteinases; Mice; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Neovascularization, Pathologic; Oligopeptides; Positron-Emission Tomography; Receptors, Immunologic; Receptors, Peptide; Receptors, Vascular Endothelial Growth Factor | 2009 |
Imaging atherosclerosis and vulnerable plaque.
Topics: Animals; Atherosclerosis; Clinical Trials as Topic; Contrast Media; Extracellular Matrix; Ferric Compounds; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Nanoparticles; Neovascularization, Pathologic; Risk; Thrombosis; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2010 |
The role of functional imaging in colorectal cancer.
Topics: Colorectal Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Molecular imaging metrics to evaluate response to preclinical therapeutic regimens.
Topics: Diagnostic Imaging; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Neoplasms; Neovascularization, Pathologic; Positron-Emission Tomography; Thymidine Kinase | 2011 |
Sonographic depiction of microvessel perfusion: principles and potential.
Topics: Animals; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Microbubbles; Neoplasms; Neoplasms, Experimental; Neovascularization, Pathologic; Radiopharmaceuticals; Regional Blood Flow; Ultrasonography, Doppler, Color | 2004 |
[Assessment of tumor radiosensitivity using functional and metabolic nuclear imaging in research and clinical practice. A review].
Topics: Cell Hypoxia; Cell Proliferation; Fluorodeoxyglucose F18; Humans; Neoplasms; Neovascularization, Pathologic; Radiation Tolerance; Radionuclide Imaging; Radiopharmaceuticals | 2006 |
Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics.
Topics: Anaerobiosis; Animals; Biological Transport; Fluorodeoxyglucose F18; Glucose; Glucose Transport Proteins, Facilitative; Glucose Transporter Type 1; Glucose Transporter Type 3; Glycolysis; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Neoplasms; Neovascularization, Pathologic; Positron-Emission Tomography | 2007 |
New approaches for imaging tumour responses to treatment.
Topics: Animals; Clinical Trials as Topic; Diagnostic Imaging; Fluorodeoxyglucose F18; Glycolysis; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Neoplasms; Neovascularization, Pathologic; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography | 2008 |
Molecular imaging of atherosclerosis.
Topics: Arteriosclerosis; Biotechnology; Fluorodeoxyglucose F18; History, 20th Century; Humans; Inflammation; Integrins; Lipid Metabolism; Lipoproteins, LDL; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Radiopharmaceuticals | 2008 |
12 trial(s) available for fluorodeoxyglucose f18 and Angiogenesis, Pathologic
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Multifunctional Assessment of Non-Small Cell Lung Cancer: Perfusion-Metabolic Correlation.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Positron Emission Tomography Computed Tomography; Tumor Burden | 2018 |
Pilot study of combined FDG-PET and dynamic contrast-enhanced CT of locally advanced cervical carcinoma before and during concurrent chemoradiotherapy suggests association between changes in tumor blood volume and treatment response.
Topics: Adult; Aged; Blood Volume; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Neovascularization, Pathologic; Pilot Projects; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2018 |
18F-FDG PET-Derived Tumor Blood Flow Changes After 1 Cycle of Neoadjuvant Chemotherapy Predicts Outcome in Triple-Negative Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Antineoplastic Agents; Blood Flow Velocity; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Neovascularization, Pathologic; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Triple Negative Breast Neoplasms | 2016 |
¹⁸F-FDG PET and biomarkers for tumour angiogenesis in early breast cancer.
Topics: Aged; Biological Transport; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neovascularization, Pathologic; Positron-Emission Tomography | 2011 |
Evaluation of breast tumor blood flow with dynamic first-pass 18F-FDG PET/CT: comparison with angiogenesis markers and prognostic factors.
Topics: Adult; Aged; Biomarkers, Tumor; Blood Circulation; Breast Neoplasms; Cell Proliferation; Endothelial Cells; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Middle Aged; Multimodal Imaging; Neovascularization, Pathologic; Positron-Emission Tomography; Prognosis; Prospective Studies; Tomography, X-Ray Computed | 2012 |
The flow-metabolic phenotype of primary colorectal cancer: assessment by integrated 18F-FDG PET/perfusion CT with histopathologic correlation.
Topics: Aged; Aged, 80 and over; Cell Hypoxia; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neovascularization, Pathologic; Perfusion Imaging; Phenotype; Positron-Emission Tomography; Regional Blood Flow; Tomography, X-Ray Computed | 2012 |
Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin.
Topics: Adenocarcinoma; Adult; Aged; Angiogenesis Inhibitors; Apoptosis; Biomarkers; CD3 Complex; Collagen; Dose-Response Relationship, Drug; Endostatins; Endothelium; Female; Fluorodeoxyglucose F18; Humans; In Situ Nick-End Labeling; Lasers; Male; Middle Aged; Neoplasms; Neovascularization, Pathologic; Peptide Fragments; Prospective Studies; Recombinant Proteins; Tomography, Emission-Computed | 2002 |
Relationships between oxygen and glucose metabolism in human liver tumours: positron emission tomography using (15)O and (18)F-deoxyglucose.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Glucose; Humans; Liver; Liver Neoplasms; Middle Aged; Neovascularization, Pathologic; Oxygen; Oxygen Radioisotopes; Positron-Emission Tomography; Radiopharmaceuticals; Statistics as Topic | 2004 |
Randomized phase II trial of the anti-angiogenic potential of doxorubicin and docetaxel; primary chemotherapy as Biomarker Discovery Laboratory.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Drug Administration Schedule; Female; Fibroblast Growth Factor 2; Fluorodeoxyglucose F18; Humans; Microcirculation; Middle Aged; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome; Ultrasonography, Doppler, Color | 2005 |
Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography.
Topics: Blood Flow Velocity; Contrast Media; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Statistics as Topic; Tomography, X-Ray Computed | 2006 |
Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies.
Topics: Adult; Aged; Brain; Brain Neoplasms; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Male; Metabolic Clearance Rate; Middle Aged; Misonidazole; Neovascularization, Pathologic; Oxygen; Radionuclide Imaging; Radiopharmaceuticals; Statistics as Topic | 2006 |
62 other study(ies) available for fluorodeoxyglucose f18 and Angiogenesis, Pathologic
Article | Year |
---|---|
Comparison of a New
Topics: Animals; CD146 Antigen; Disease Models, Animal; Fibrosis; Fluorodeoxyglucose F18; Gallium Radioisotopes; Integrin alphaVbeta3; Male; Mice; Myocardial Infarction; Myocardium; Neovascularization, Pathologic; Oligopeptides; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
A spatiotemporal multi-scale computational model for FDG PET imaging at different stages of tumor growth and angiogenesis.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasms; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Microenvironment | 2022 |
Advanced ultrasound methods in assessment of carotid plaque instability: a prospective multimodal study.
Topics: Aged; Carotid Arteries; Carotid Stenosis; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neovascularization, Pathologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Prospective Studies; Ultrasonography | 2020 |
Micro-positron emission tomography imaging of angiogenesis based on
Topics: Animals; Colorectal Neoplasms; Fluorodeoxyglucose F18; Ki-67 Antigen; Liver Neoplasms; Mice; Neovascularization, Pathologic; Oligopeptides; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2021 |
The Distribution Volume of
Topics: Albumins; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, Nude; Neoplasms; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Sunitinib; Tissue Distribution; Treatment Outcome; Xenograft Model Antitumor Assays | 2019 |
A Comparison of Angiogenesis and Glycolytic Imaging in Patients With Clinical Suspected Locally Advanced Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Positron Emission Tomography Computed Tomography | 2019 |
Combined parameter SUVmax/ADCmean predicts microvessel density in head and neck squamous cell carcinoma. Preliminary results.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Microvessels; Multimodal Imaging; Neovascularization, Pathologic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; ROC Curve; Squamous Cell Carcinoma of Head and Neck | 2020 |
Fasting 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Antigens, CD; Cell Hypoxia; Echocardiography; Erythropoietin; Familial Primary Pulmonary Hypertension; Female; Fluorodeoxyglucose F18; Glucose; Heart Ventricles; Humans; Hypertension, Pulmonary; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Monitoring, Physiologic; Neovascularization, Pathologic; Positron-Emission Tomography; Reproducibility of Results; Ventricular Dysfunction, Right | 2013 |
Early dynamic 18F-FDG PET to detect hyperperfusion in hepatocellular carcinoma liver lesions.
Topics: Adult; Aged; Blood Circulation; Carcinoma, Hepatocellular; Endpoint Determination; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Positron-Emission Tomography; Time Factors; Whole Body Imaging | 2013 |
Glucose transporter-1 distribution in fibrotic lung disease: association with [¹⁸F]-2-fluoro-2-deoxyglucose-PET scan uptake, inflammation, and neovascularization.
Topics: Adult; Aged; Bronchoalveolar Lavage Fluid; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hermanski-Pudlak Syndrome; Humans; Inflammation; Male; Microscopy, Confocal; Middle Aged; Neovascularization, Pathologic; Positron-Emission Tomography; Pulmonary Fibrosis; Radiopharmaceuticals | 2013 |
Neovascularization in the carotid atherosclerotic plaque is not associated with inflammatory cell aggregation.
Topics: Aged; Aged, 80 and over; Carotid Artery Diseases; Cell Aggregation; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Macrophages; Magnetic Resonance Imaging; Male; Middle Aged; Neovascularization, Pathologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Combined 18F-FDG PET-CT and DCE-MRI to assess inflammation and microvascularization in atherosclerotic plaques.
Topics: Aged; Brain Ischemia; Carotid Stenosis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Multimodal Imaging; Neovascularization, Pathologic; Plaque, Atherosclerotic; Radionuclide Imaging; Radiopharmaceuticals; Stroke | 2013 |
¹⁸F-FDG uptake on PET is a predictive marker of thymidylate synthase expression in patients with thoracic neoplasms.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD34; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Dihydrouracil Dehydrogenase (NADP); Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Microvessels; Middle Aged; Neovascularization, Pathologic; Neuroendocrine Tumors; Orotate Phosphoribosyltransferase; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Neoplasms; Thymidylate Synthase; Thymus Neoplasms; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A; Young Adult | 2014 |
Optical imaging of tumor vascularity associated with proliferation and glucose metabolism in early breast cancer: clinical application of total hemoglobin measurements in the breast.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Cell Proliferation; Female; Fluorodeoxyglucose F18; Glucose; Hemoglobins; Humans; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Optical Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2013 |
Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer.
Topics: Antigens, CD34; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 3; Hexokinase; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Neovascularization, Pathologic; Positron-Emission Tomography; Prognosis; PTEN Phosphohydrolase; Signal Transduction; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A | 2014 |
Evaluation of synovial angiogenesis in patients with rheumatoid arthritis using ⁶⁸Ga-PRGD2 PET/CT: a prospective proof-of-concept cohort study.
Topics: Adult; Arthritis, Rheumatoid; Case-Control Studies; Cohort Studies; Female; Fluorodeoxyglucose F18; Gadolinium; Humans; Male; Middle Aged; Multimodal Imaging; Neovascularization, Pathologic; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Synovial Membrane; Tomography, X-Ray Computed | 2014 |
Multimodality multiparametric imaging of early tumor response to a novel antiangiogenic therapy based on anticalins.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Fluorodeoxyglucose F18; Lipocalins; Magnetic Resonance Imaging; Mice; Multimodal Imaging; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Increased microvascularization and vessel permeability associate with active inflammation in human atheromata.
Topics: Aged; Biomarkers; Capillary Permeability; Carotid Arteries; Carotid Stenosis; Contrast Media; Female; Fluorodeoxyglucose F18; Histocompatibility Antigens Class II; Humans; Inflammation; Inflammation Mediators; Linear Models; Macrophages; Magnetic Resonance Imaging; Male; Microvessels; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neovascularization, Pathologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Severity of Illness Index; Tomography, X-Ray Computed | 2014 |
Prediction of microvascular invasion of hepatocellular carcinoma using gadoxetic acid-enhanced MR and (18)F-FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microvessels; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neovascularization, Pathologic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET.
Topics: Biomarkers; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Immunohistochemistry; Neoplasm Grading; Neoplasm Staging; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Tumor Burden | 2014 |
(18)F-FDG uptake on PET correlates with biological potential in early oral squamous cell carcinoma.
Topics: Adult; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Neovascularization, Pathologic; Positron-Emission Tomography; Prognosis; Statistics as Topic; Tongue Neoplasms | 2015 |
Improving Cerebral Blood Flow Through Liposomal Delivery of Angiogenic Peptides: Potential of ¹⁸F-FDG PET Imaging in Ischemic Stroke Treatment.
Topics: Animals; Brain; Brain Ischemia; Cerebrovascular Circulation; Drug Delivery Systems; Fluorodeoxyglucose F18; Glucose; Ischemia; Liposomes; Male; Multimodal Imaging; Neovascularization, Pathologic; Peptides; Perfusion; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Stroke; Technetium; Technetium Tc 99m Exametazime; Tomography, X-Ray Computed | 2015 |
High resolution FDG-microPET of carotid atherosclerosis: plaque components underlying enhanced FDG uptake.
Topics: Aged; Aged, 80 and over; Carotid Arteries; Carotid Artery Diseases; Endarterectomy, Carotid; Female; Fibrosis; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neovascularization, Pathologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Vascular Calcification | 2016 |
Hyaluronic acid-serum hydrogels rapidly restore metabolism of encapsulated stem cells and promote engraftment.
Topics: Animals; Biocompatible Materials; Cell Adhesion; Cell Proliferation; Cell Survival; Cell Transplantation; Echocardiography; Elastic Modulus; Embryonic Stem Cells; Female; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Hyaluronic Acid; Hydrogels; Intercellular Signaling Peptides and Proteins; Male; Mesenchymal Stem Cells; Mice; Multimodal Imaging; Myocardium; Neovascularization, Pathologic; Rats; Rats, Inbred WKY; Stem Cell Transplantation; Stem Cells; Tissue Engineering; Tissue Scaffolds; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2015 |
18F-FDG, as a single imaging agent in assessing cancer, shows the ongoing biological phenomena in many domains: do we need additional tracers for clinical purposes?
Topics: Cell Proliferation; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Neoplasms; Neovascularization, Pathologic; Positron-Emission Tomography; Radioactive Tracers | 2016 |
The feasibility of 18F-AlF-NOTA-PRGD2 PET/CT for monitoring early response of Endostar antiangiogenic therapy in human nasopharyngeal carcinoma xenograft model compared with 18F-FDG.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cells, Cultured; Drug Monitoring; Endostatins; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Integrin alphaVbeta3; Mice; Nasopharyngeal Neoplasms; Neovascularization, Pathologic; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Recombinant Proteins; Reproducibility of Results; Xenograft Model Antitumor Assays | 2016 |
Prognostic Value of 68Ga-NOTA-RGD PET/CT for Predicting Disease-Free Survival for Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy and Surgery: A Comparison Study With Dynamic Contrast Enhanced MRI.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Contrast Media; Coordination Complexes; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Epirubicin; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Kaplan-Meier Estimate; Lymph Node Excision; Magnetic Resonance Imaging; Mastectomy; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Oligopeptides; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Taxoids | 2016 |
Identification of Angiogenesis Rich-Viable Myocardium using RGD Dimer based SPECT after Myocardial Infarction.
Topics: Animals; Fluorodeoxyglucose F18; Integrin alphaVbeta3; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Neovascularization, Pathologic; Oligopeptides; Organotechnetium Compounds; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tomography, Emission-Computed, Single-Photon | 2016 |
68Ga-NODAGA-RGDyK PET/CT Imaging in Esophageal Cancer: First-in-Human Imaging.
Topics: Adult; Carcinoma; Coordination Complexes; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Male; Neovascularization, Pathologic; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Spatiotemporal distribution modeling of PET tracer uptake in solid tumors.
Topics: Algorithms; Computer Simulation; Diffusion; Fluorodeoxyglucose F18; Humans; Models, Biological; Neoplasms; Neovascularization, Pathologic; Positron-Emission Tomography; Pressure; Radiopharmaceuticals | 2017 |
Secreted frizzled-related protein 1 overexpression in gastric cancer: Relationship with radiological findings of dual-energy spectral CT and PET-CT.
Topics: Animals; Biological Assay; Cell Line, Tumor; Cell Proliferation; Female; Fluorodeoxyglucose F18; Gene Expression; Human Umbilical Vein Endothelial Cells; Humans; Intercellular Signaling Peptides and Proteins; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Positron Emission Tomography Computed Tomography; Stomach Neoplasms; Tomography, X-Ray Computed; Transgenes; Up-Regulation | 2017 |
Assessment of intratumor hypoxia by integrated 18F-FDG PET / perfusion CT in a liver tumor model.
Topics: Animals; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Liver Neoplasms; Male; Neovascularization, Pathologic; Nitroimidazoles; Oxygen Consumption; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rabbits | 2017 |
Impact of angiogenesis-related gene expression on the tracer kinetics of 18F-FDG in colorectal tumors.
Topics: Angiopoietin-2; Colorectal Neoplasms; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Neovascularization, Pathologic; Oligonucleotide Array Sequence Analysis; Positron-Emission Tomography; Radiopharmaceuticals; Vascular Endothelial Growth Factor A | 2008 |
Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Antigens, CD34; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Large Neutral Amino Acid-Transporter 1; Lung Neoplasms; Male; Microvessels; Middle Aged; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Positron-Emission Tomography; Radiopharmaceuticals; Thoracotomy; Vascular Endothelial Growth Factor A | 2009 |
Functional response imaging following neoadjuvant therapy for rectal cancer.
Topics: Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Molecular Imaging; Neoadjuvant Therapy; Neovascularization, Pathologic; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rectal Neoplasms; Treatment Outcome | 2009 |
Hyaluronan mixed esters of butyric and retinoic acid affording myocardial survival and repair without stem cell transplantation.
Topics: Animals; Butyric Acid; Cell Survival; Fluorodeoxyglucose F18; Gene Transfer Techniques; Hyaluronic Acid; Magnetic Resonance Imaging; Male; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Neovascularization, Pathologic; Positron-Emission Tomography; Rats; Rats, Wistar; Stem Cell Transplantation; Tretinoin | 2010 |
Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Biopsy; Brain Neoplasms; Choline; Contrast Media; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Glioma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Microcirculation; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Spin Labels; Stereotaxic Techniques | 2010 |
Preliminary study on the correlation between grading and histology of solitary pulmonary nodules and contrast enhancement and [18F]fluorodeoxyglucose standardised uptake value after evaluation by dynamic multiphase CT and PET/CT.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2011 |
Multiplexed PET probes for imaging breast cancer early response to VEGF₁₂₁/rGel treatment.
Topics: Animals; Breast Neoplasms; Cell Proliferation; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Mice; Mice, Nude; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Ribosome Inactivating Proteins, Type 1; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2011 |
FDG PET/CT early dynamic blood flow and late standardized uptake value determination in hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Blood Flow Velocity; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Statistics, Nonparametric; Tomography, X-Ray Computed | 2011 |
Increased glucose metabolism by FDG-PET correlates with reduced tumor angiogenesis in oral squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Male; Middle Aged; Mouth Neoplasms; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Statistics, Nonparametric | 2012 |
Microvessel density but not neoangiogenesis is associated with 18F-FDG uptake in human atherosclerotic carotid plaques.
Topics: Aged; Aged, 80 and over; Antigens, CD34; Carotid Stenosis; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Integrins; Linear Models; Male; Microvessels; Middle Aged; Neovascularization, Pathologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Vascular Endothelial Growth Factor A | 2012 |
Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Aortography; Atherosclerosis; Biomarkers; Contrast Media; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Immunohistochemistry; Inflammation; Lipids; Macrophages; Magnetic Resonance Angiography; Multimodal Imaging; Neovascularization, Pathologic; Pioglitazone; Positron-Emission Tomography; PPAR gamma; Predictive Value of Tests; Rabbits; Radiopharmaceuticals; Thiazolidinediones; Time Factors; Tomography, X-Ray Computed | 2011 |
Maximal standardized uptake value on FDG-PET is correlated with cyclooxygenase-2 expression in patients with lung adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biomarkers, Tumor; Cyclooxygenase 2; Disease-Free Survival; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Intercellular Signaling Peptides and Proteins; Kaplan-Meier Estimate; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Proteins; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Early dynamic PET imaging shows hypervascularization as exact as contrast-enhanced MR.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multimodal small-animal PET and MRI.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Data Interpretation, Statistical; Dideoxynucleosides; Disease Progression; Fluorodeoxyglucose F18; Glioblastoma; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Ki-67 Antigen; Magnetic Resonance Imaging; Methionine; Neoplasm Transplantation; Neovascularization, Pathologic; Paraffin Embedding; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude; Xenograft Model Antitumor Assays | 2012 |
Cilengitide affects tumor compartment, vascularization and microenvironment in experimental bone metastases as shown by longitudinal ¹⁸F-FDG PET and gene expression analysis.
Topics: Animals; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Integrin alphaVbeta3; Longitudinal Studies; Male; Neovascularization, Pathologic; Oligonucleotide Array Sequence Analysis; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude; Real-Time Polymerase Chain Reaction; Receptors, Vitronectin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Snake Venoms; Tumor Cells, Cultured; Tumor Microenvironment | 2013 |
Measurement of perfusion in stage IIIA-N2 non-small cell lung cancer using H(2)(15)O and positron emission tomography.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Oxygen Radioisotopes; Prognosis; Tomography, Emission-Computed; Water | 2002 |
Molecular (functional) imaging for radiotherapy applications: an RTOG symposium.
Topics: Animals; Biomarkers, Tumor; Cell Hypoxia; Fluorodeoxyglucose F18; Humans; Neoplasm Proteins; Neoplasms; Neovascularization, Pathologic; Radiation Tolerance; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Receptors, Cell Surface; Research; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2003 |
In vivo trafficking of endothelial progenitor cells their possible involvement in the tumor neovascularization.
Topics: Animals; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Endothelium, Vascular; Fluorodeoxyglucose F18; Gamma Rays; Hydroxamic Acids; Metalloendopeptidases; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; Pyrazines; Rats; Stem Cells; Sulfonamides; Tomography, Emission-Computed | 2004 |
Integrin alpha v beta 3-targeted imaging of lung cancer.
Topics: Animals; Cell Adhesion; Chromatography, High Pressure Liquid; Copper; Dimerization; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Humans; Integrin alphaVbeta3; Kinetics; Lung; Lung Neoplasms; Male; Mice; Mice, SCID; Microscopy, Fluorescence; Models, Chemical; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Oligopeptides; Peptides; Polyethylene Glycols; Positron-Emission Tomography; Protein Binding; Protein Structure, Tertiary; Radiopharmaceuticals; Time Factors | 2005 |
Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors.
Topics: Adult; Aged; Angiography; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neovascularization, Pathologic; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Stable RNA interference-mediated suppression of cyclophilin A diminishes non-small-cell lung tumor growth in vivo.
Topics: Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Growth Processes; Cell Line, Tumor; Cyclophilin A; Fluorodeoxyglucose F18; Lung Neoplasms; Mice; Mice, Nude; Neovascularization, Pathologic; RNA Interference; Transfection | 2005 |
Microvessel density: correlation with 18F-FDG uptake and prognostic impact in lung adenocarcinomas.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Lung Neoplasms; Male; Microcirculation; Middle Aged; Neovascularization, Pathologic; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2006 |
18-Fluorine-labelled 2-deoxy-2-fluoro-D-glucose positron emission tomography/computed tomography standardised uptake values: a non-invasive biomarker for the risk of metastasis from choroidal melanoma.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Choroid Neoplasms; Eye Enucleation; Fluorodeoxyglucose F18; Humans; Melanoma; Middle Aged; Necrosis; Neovascularization, Pathologic; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2006 |
Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Misonidazole; Neovascularization, Pathologic; Radionuclide Imaging; Radiopharmaceuticals; Statistics as Topic | 2006 |
Measuring tumor perfusion in control and treated murine tumors: correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography.
Topics: Animals; Cell Line, Tumor; Contrast Media; Fluorocarbons; Fluorodeoxyglucose F18; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography | 2007 |
Analysis of blood flow and glucose metabolism in mammary carcinomas and normal breast: a H2(15)O PET and 18F-FDG PET study.
Topics: Adult; Aged; Blood Flow Velocity; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Humans; Metabolic Clearance Rate; Middle Aged; Neovascularization, Pathologic; Oxygen Radioisotopes; Positron-Emission Tomography; Tissue Distribution; Water | 2007 |
Antitumor and antivascular effects of AVE8062 in ovarian carcinoma.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cell Growth Processes; Cell Line, Tumor; Docetaxel; Female; Fluorodeoxyglucose F18; G2 Phase; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Serine; Taxoids; Xenograft Model Antitumor Assays | 2007 |
Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET.
Topics: Animals; Aortic Diseases; Area Under Curve; Atherosclerosis; Catheterization; Cholesterol, Dietary; Contrast Media; Disease Models, Animal; Fluorodeoxyglucose F18; Gadolinium DTPA; Magnetic Resonance Angiography; Male; Neovascularization, Pathologic; Positron-Emission Tomography; Predictive Value of Tests; Rabbits; Radiopharmaceuticals; Research Design | 2008 |
Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenog
Topics: Animals; Blood Volume; Brain Neoplasms; Capillary Permeability; Cerebrovascular Circulation; Endothelial Growth Factors; Enzyme-Linked Immunosorbent Assay; Fluorodeoxyglucose F18; Humans; Lymphokines; Melanoma; Mice; Neoplasm Proteins; Neovascularization, Pathologic; RNA, Antisense; Transfection; Transplantation, Heterologous; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neovascularization, Pathologic; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Tomography, Emission-Computed | 2002 |